Press Releases Endonovo Therapeutics, Inc.

Equities

ENDV

US29272H3003

Market Closed - OTC Markets Other stock markets 10:45:08 2024-04-26 am EDT			5-day change	1st Jan Change
0.00263 ^USD	+9.58%		0.00%	-70.11%

2023	Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc	Mar. 28	AQ
Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions	Mar. 04	AQ
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million	Dec. 04	AQ
Endonovo's SofPulse® Secures Taiwan FDA Approval	23-10-12	AQ
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution	23-08-22	AQ
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update	23-08-08	AQ
New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.	23-06-22	AQ
Endonovo Pending Agreement to Develop Telehealth Division	23-06-07	AQ
Endonovo Launches SofPulse® into the Veterans Administration	23-05-02	AQ
Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies	23-04-25	AQ
ENDONOVO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-04-17	AQ
Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman	23-04-13	AQ
Endonovo Announces Partnership with Santana Lead Singer Andy Vargas	23-04-10	AQ
Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company	23-03-29	AQ
ENDONOVO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-03-29	AQ
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan	23-03-23	AQ
Olympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgery	23-03-15	AQ
Endonovo Announces Distribution Agreement with Academy Medical	23-03-06	AQ
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg	23-02-28	AQ
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off	23-01-31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Endonovo Therapeutics, Inc.

Equities

ENDV

US29272H3003

Press Releases

Filters